申请人:Takeda Pharmaceutical Company Limited
公开号:US08329691B2
公开(公告)日:2012-12-11
A renin inhibitor comprising a compound represented by the formula:
wherein each symbol is as defined in the description, or a salt thereof or a prodrug thereof. The compound of the present invention has a superior renin inhibitory activity, and thus is useful as an agent for the prophylaxis or treatment of hypertension, various organ damages attributable to hypertension and the like.
一种肾素抑制剂,包括由下式表示的化合物:其中每个符号如描述中所定义,或其盐或前药。本发明的化合物具有优异的肾素抑制活性,因此可用作预防或治疗高血压、由高血压引起的各种器官损伤等的药剂。